KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

In mild to moderate COVID-19, VV116 safely reduced time to sustained clinical symptom resolution.

Bruno Palma Granwehr

Ann Intern Med 177(3) JC35

PMID38437701
PMCID-
DOI10.7326/J24-0006
发表日期2024-03-04
摘要

摘要

Fan X, Dai X, Ling Y, et al. Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled study. Lancet Infect Dis. 2024;24:129-139. 38006892.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。